shot-button
E-paper E-paper
Home > News > India News > Article > Bharat Biotech gets Centres letter for 45 lakh doses of Covaxin Report

Bharat Biotech gets Centre's letter for 45 lakh doses of Covaxin: Report

Updated on: 19 January,2021 12:00 AM IST  |  Hyderabad
PTI |

Bharat Biotech said it has also donated 16.5 lakh doses to the Government of India.

Bharat Biotech gets Centre's letter for 45 lakh doses of Covaxin: Report

Photo used for representational purpose

Bharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said.


Out of the 45 lakh doses, the Hyderabad-based vaccine maker will be supplying over eight lakh to some of the friendly countries such as Mauritius, Philippines and Myanmar, free of cost as good will gesture, sources told news agency Press Trust of India.


"The company was given a fresh letter of comfort recently for supplying another 45 lakh doses of Covaxin. The doses will be dispatched as when the Ministry places orders with the company," sources told news agency PTI.


After having received the government purchase order for 55lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow, it said.

Bharat Biotech said it has also donated 16.5 lakh doses to the Government of India.

Sources further said the supplies from the company depend on the orders being placed by the government.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK